CONTACT:
Beth Gabrini, TMH, (850) 431-5875;
Beth.Gabrini@tmh.org
Doug Carlson, FSU College of Medicine, (850) 645-1255;
doug.carlson@med.fsu.edu
By Jill Elish
April 2009FLORIDA STATE UNIVERSITY ENTERS
RESEARCH PARTNERSHIP
WITH TALLAHASSEE MEMORIAL HEALTHCARE
TALLAHASSEE, Fla. -- Florida State University and Tallahassee
Memorial HealthCare have signed an agreement to work as research
partners on projects with potential to directly impact health care
in the Big Bend and across Florida.
The agreement will allow Tallahassee Memorial Hospital’s more than
500 affiliated physicians, many of whom already serve as members of
the FSU College of Medicine clinical faculty, to conduct laboratory
research and clinical trials with university researchers from the
medical school as well as other colleges and departments.
“This is the beginning of a unique research effort,” said Florida
State President T.K. Wetherell. “In community partnerships such as
the one we are forging with TMH, we will be able to provide a body
of knowledge through which Florida’s citizens will see unprecedented
health care benefits.”
Mark O’Bryant, president and chief executive officer of Tallahassee
Memorial HealthCare, said TMH is honored to be in the vanguard of
this statewide effort to improve health care through research.
“This partnership presents a golden opportunity to bring great minds
together,” O’Bryant said. “We believe the result of their work will
be a healthier community for us all.”
Unlike traditional medical schools where research takes place both
in labs and in an academic medical center, the FSU College of
Medicine has no single teaching hospital. Instead, the college
counts more than 60 teaching hospitals, clinics and community health
care centers around the state of Florida as partners in educating
medical students. Physicians across Florida are part of the
college’s clerkship faculty, meaning they agree to teach a required
or elective rotation to one or two third- or fourth-year medical
students at a time.
The College of Medicine previously had no mechanism in place for
physicians who serve as clinical faculty to participate in or lead
university research projects. With this agreement with TMH, the
College of Medicine now has a model that could be extended to other
community hospitals where FSU medical students learn. This would
provide a foundation for the clinical research program with the
potential to involve more than 1,500 physicians and their 2 million
patients.
“Such a network would give the FSU College of Medicine perhaps the
most dynamic and all-encompassing medical research program in the
state,” said Myra Hurt, senior associate dean for research and
graduate programs at the College of Medicine. “Few medical schools
anywhere would have access to more patients of varied backgrounds
and covering all of the stages of disease processes across the full
continuum of human aging.”
The National Institutes of Health is pushing for an emphasis on
translating discoveries from the laboratory into improved patient
care, according to Dr. John P. Fogarty, dean of the College of
Medicine. The agreement between TMH and FSU puts the “bench to
bedside to community” philosophy into practice by allowing
physicians and researchers to conduct clinical trials and develop
new treatments for a multitude of diseases. The partners already are
developing initiatives for neurological and genetic associated
diseases under this agreement.
Dr. Charles G. “Gerry” Maitland, a professor of clinical sciences
and director of the FSU Neurological Research Institute who also is
in private practice in Tallahassee, said patients will be the
beneficiaries of these initiatives.
“The presence of a translational laboratory coupled with the
uniqueness of the College of Medicine’s six campuses, places us on
the cutting edge of investigative technologies,” Maitland said.
“Consequently, patients treated here at TMH and at the other five
campuses will have available to them the most advanced and
innovative treatments.”
The FSU-TMH agreement will set the stage for more collaborative
efforts, such as the Tallahassee Memorial HealthCare and College of
Medicine/College of Communication Neurolinguistic-Neurocognitive
Research Center founded in 2005 and housed at TMH. Maitland and
Leonard LaPointe, the FSU Francis Eppes Professor of Communication
Disorders, serve as co-directors of the center, which was
established to research the effects of cognitive dysfunction and
develop new therapies for patients. The center aspires to be
recognized as one of the premier clinical research centers in the
country for brain-behavior disorders.
Paula Fortunas, president and chief executive officer of the TMH
Foundation, said increasing physician and hospital clinical research
is a key component of TMH’s strategic plan.
“The FSU-TMH partnership is truly a powerful one, and this research
collaboration agreement represents another measure of that strength
as it outlines the long-range vision of the two institutions and
opens medical, clinical and educational initiatives to serve the
greater good,” she said.
Tallahassee Memorial HealthCare, Inc. is a not-for-profit,
comprehensive system of health care services that include
Tallahassee Memorial Hospital, the seventh largest hospital in
Florida; a psychiatric hospital; a rehabilitation center; a family
residency program; and associated clinics and satellite facilities
in five surrounding counties.
###
|